NDC 72627-2321-5
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 72627-2321-5
- Product root
- 72627-2321
- Identity scope
- Package
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| compounder | package | 72627-2321 | 72627-2321-5 | COMPOUNDER | Outsourcing facility compounded drug report | 2025-1 | 2026-08-12 |
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| Empower Pharma | 831178947 | 72627-2321 | 72627-2321-5 | Cyanocobalamin; Semaglutide | .5 mg/1 mL; 1 mg/1 mL | 2025-1 | valid |
| Empower Pharma | 831178947 | 72627-2321 | 72627-2321-6 | Cyanocobalamin; Semaglutide | .5 mg/1 mL; 1 mg/1 mL | 2025-1 | valid |